MAVILIO, Fulvio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.298
AS - Asia 9.939
EU - Europa 7.721
SA - Sud America 1.262
Continente sconosciuto - Info sul continente non disponibili 342
AF - Africa 206
OC - Oceania 39
Totale 39.807
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.902
SG - Singapore 4.106
GB - Regno Unito 2.124
CN - Cina 1.974
IT - Italia 1.404
HK - Hong Kong 1.337
BR - Brasile 1.000
RU - Federazione Russa 984
VN - Vietnam 826
SE - Svezia 741
FI - Finlandia 650
DE - Germania 528
BD - Bangladesh 452
FR - Francia 334
UA - Ucraina 274
KR - Corea 256
BG - Bulgaria 220
CA - Canada 217
TR - Turchia 211
IN - India 162
ID - Indonesia 130
MX - Messico 96
JP - Giappone 95
NL - Olanda 95
AR - Argentina 93
IQ - Iraq 71
IE - Irlanda 61
AE - Emirati Arabi Uniti 54
ZA - Sudafrica 53
BE - Belgio 47
EC - Ecuador 44
PL - Polonia 40
AU - Australia 36
ES - Italia 36
CO - Colombia 33
MA - Marocco 32
UZ - Uzbekistan 32
EG - Egitto 31
PK - Pakistan 31
VE - Venezuela 31
AT - Austria 30
CL - Cile 24
PH - Filippine 22
LT - Lituania 19
MY - Malesia 19
SA - Arabia Saudita 19
SI - Slovenia 19
TN - Tunisia 19
BZ - Belize 18
TH - Thailandia 16
CH - Svizzera 14
KE - Kenya 14
AZ - Azerbaigian 13
DZ - Algeria 13
IR - Iran 13
BO - Bolivia 12
CZ - Repubblica Ceca 12
DK - Danimarca 12
NP - Nepal 12
CR - Costa Rica 11
JO - Giordania 11
KZ - Kazakistan 10
LU - Lussemburgo 10
PT - Portogallo 10
RO - Romania 10
TW - Taiwan 10
GR - Grecia 9
PY - Paraguay 9
NG - Nigeria 8
PA - Panama 8
PE - Perù 8
DO - Repubblica Dominicana 7
ET - Etiopia 7
HN - Honduras 7
IL - Israele 7
JM - Giamaica 7
OM - Oman 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
BY - Bielorussia 6
MD - Moldavia 6
NI - Nicaragua 6
CI - Costa d'Avorio 5
SN - Senegal 5
AL - Albania 4
BH - Bahrain 4
CY - Cipro 4
EU - Europa 4
GT - Guatemala 4
HU - Ungheria 4
PS - Palestinian Territory 4
QA - Qatar 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
AO - Angola 3
GE - Georgia 3
GH - Ghana 3
Totale 39.420
Salva come PNG Salva come JPEG
Città #
Singapore 2.949
Ashburn 2.143
Fairfield 2.045
Santa Clara 2.006
Hong Kong 1.313
Southend 1.212
Woodbridge 1.089
Chandler 952
Houston 944
San Jose 886
Wilmington 671
Seattle 660
Cambridge 628
Ann Arbor 596
Helsinki 562
London 555
Jacksonville 506
Nyköping 455
Beijing 440
Hefei 402
Dearborn 388
Los Angeles 363
Council Bluffs 341
Chicago 325
The Dalles 320
San Diego 278
Modena 245
Ho Chi Minh City 241
Seoul 226
Princeton 221
Sofia 214
New York 196
Milan 191
Hanoi 183
Buffalo 140
Salt Lake City 140
Bremen 119
Eugene 102
Shanghai 96
Jakarta 91
Dallas 89
Lauterbourg 89
Moscow 88
Elk Grove Village 78
Izmir 75
São Paulo 75
Des Moines 64
Dublin 61
Phoenix 61
Rome 57
Tampa 57
Dong Ket 52
Frankfurt am Main 52
Tokyo 47
San Francisco 45
Toronto 45
Atlanta 44
Brussels 43
Da Nang 43
Columbus 39
Redwood City 38
Redondo Beach 37
Norwalk 36
Rio de Janeiro 36
Vancouver 35
Boardman 34
Brooklyn 34
Guangzhou 34
Belo Horizonte 33
Haiphong 33
Orem 32
Burlington 31
Miano 31
Mexico City 30
Montreal 30
Baghdad 29
Bonndorf 29
Lancaster 29
Nuremberg 28
Paris 28
Delft 27
Falls Church 27
Munich 27
Hounslow 26
Sterling 26
Tashkent 25
Warsaw 25
Naples 24
North Bergen 23
Cairo 22
Dhaka 22
Kilburn 22
Las Vegas 22
Denver 21
Chennai 20
Melbourne 20
Brasília 19
Johannesburg 19
Nanjing 19
Philadelphia 19
Totale 27.740
Salva come PNG Salva come JPEG
Nome #
Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions 905
High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors 436
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 433
IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors 432
PPARδ is a ligand-dependent negative regulator of Vitamin D3-induced monocyte differentiation 415
Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. 405
Targeted Gene Addition in Human Epithelial Stem Cells by Zinc-finger Nuclease-mediated Homologous Recombination 397
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia 390
Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts 379
Mechanisms of retroviral integration and mutagenesis 376
Comprehensive genomic access to vector integration in clinical gene therapy 359
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 358
Targeted gene integration in human epidermal stem cells by Zinc-finger nuclease-mediated homologous recombination. 340
Dynamic Transcriptional and Epigenetic Regulation of Human Epidermal Keratinocyte Differentiation 337
Nuclear architecture dictates HIV-1 integration site selection 336
Site-specific integration by the adeno-associated virus rep protein 331
Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells 329
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease 327
Medicina rigenerativa e nuove frontiere terapeutiche 326
Hot spots of retroviral integrations in human CD34+ hematopoietic cells 324
A single epidermal stem cell strategy for safe ex vivo gene therapy 321
Development of a Sleeping Beauty transposon-based integration system for gene transfer in human epithelial cells 319
Definition of the transcriptional activation domains of three human HOX proteins depends on the DNA-Binding context 318
Competitive engraftment of hematopoietic stem cells genetically modified with a truncated erythropoietin receptor 318
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates. 310
C/EBPδ regulates cell cycle and self-renewal of human limbal stem cells. 306
Genome-wide definition of promoter and enhancer usage during neural induction of human embryonic stem cells 304
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion. 302
Gene therapy in combination with tissue engineering to treat epidermolysis bullosa 301
Correction of Laminin-5 Deficiency in Human Epidermal Stem Cells by Transcriptionally Targeted Lentiviral Vectors 300
Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment 298
Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein 295
Site-specific integration into the human genome: Ready for clinical application? 294
Gene therapy approaches for epidermolysis bullosa 294
Tracking gene-modified T cells in vivo. 290
Stem cell plasticity: time for a reappraisal? 287
Gene therapy of skin adhesion disorders (mini review) 287
T Lymphocytes transduced with a lentiviral vector expressing F12-Vif are protected from HIV-1 infection in an APOBEC3G-independent manner 286
Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors 285
Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human b-globin locus 285
Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID 283
Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design 279
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa 277
Estimated comparative integration hotspots identify different behaviors of retroviral gene transfer vectors 277
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells 276
Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudine-based antiretroviral combination 275
Collagen VII gene delivery via Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 274
Correction of beta-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients 274
Defining the lentiviral integrome in human hematopoietic cells 270
Muscle-derived hematopoietic stem cells are hematopoietic in origin 267
Long-term engraftment of single genetically modified epidermal stem cell-derived clones enables safety pre-assessment of human cutaneous gene therapy 261
Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy 259
Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy 259
High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors 259
Correction of murine SCID-X1 by lentiviral gene therapy using a codon-optimized IL2RG gene and minimal pretransplant conditioning 258
Gene therapy of inherited skin adhesion disorders: a critical overview 257
Bone-marrow transplantation - Failure to correct murine muscular dystrophy 257
Non viral gene transfer via Sleeping beauty transposon for Collagen VII delivery in human primary keratinocytes. 255
Functional dissection of a transcriptionally active, target specific Hox/Pbx complex. 250
The recruitment of SOX/OCT complexes and the differential activity of HOXA1 and HOXB1 modulate the Hoxb1 auto-regulatory enhancer function 248
Transcriptional targeting of lentiviral vectors by LTR enhancer replacement 246
Towards a gene therapy clinical trial for epidermolysis bullosa 245
Genome-wide analysis of alpharetroviral integration in human hematopoietic stem/progenitor cells 245
The future of gene therapy 242
Interactions between Retroviruses and the Host Cell Genome 240
Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy? 239
Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy 235
Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells 231
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome 229
Clonal analysis of stably transduced human epidermal stem cells in culture. 228
Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements 224
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy 220
Toward gene therapy of junctional epidermolysis bullosa (JEB) 219
RD2-molpack-chim3, a packaging cell line for stable production of lentiviral vectors for Anti-HIV gene therapy 218
An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype 218
Safety of retroviral gene marking with a truncated NGF receptor 217
Towards the correction of genetic defect in corneal keratinocytes from patient with macular corneal Dystrophy type II 215
Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? 214
Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study 214
Developing gene and cell therapies for rare diseases: An opportunity for synergy between academia and industry 214
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 213
Gene therapies need new development models 207
Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors 207
Translating the genomics revolution: The need for an international gene therapy consortium for monogenic diseases 206
Epithelial stem cells in corneal regeneration and epidermal gene therapy 206
Preclinical corrective gene transfer in xeroderma pigmentosum human skin stem cells 203
Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency 202
Genetic modification of somatic stem cells. The progress, problems and prospects of a new therapeutic technology 201
Differential and stage-related expression in embryonic tissues of a new human homoeobox gene 201
Repairing without cutting: A safer alternative to gene correction? 200
Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult 197
Perspectives on Best Practices for Gene Therapy Programs 196
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia 194
A human homoeo box gene specifically expressed in spinal cord during embryonic development 190
Designing lentiviral vectors for gene therapy of genetic diseases 190
Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs 184
Erratum: Genomic analysis of sleeping beauty transposon integration in human somatic cells (PLoS ONE (2014) 9:11 (e112712) DOI: 10.1371/journal.pone.0112712) 183
A novel homeo-domain protein, prep 1, forms a regulatory complex with pbx proteins in vivo 182
Two human homeobox genes, c1 and c8: Structure analysis and expression in embryonic development 174
An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency 168
Totale 27.707
Salva come PNG Salva come JPEG
Categoria #
all - tutte 189.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 189.175
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.288 0 358 213 187 83 353 166 190 403 379 608 348
2022/20232.948 356 286 243 229 384 424 46 287 398 32 141 122
2023/20242.759 82 103 93 168 345 235 253 678 144 154 172 332
2024/20256.512 187 55 68 494 1.324 934 338 365 789 471 710 777
2025/202613.855 701 445 866 1.380 2.794 945 1.691 696 1.292 1.252 1.011 782
2026/2027487 478 9 0 0 0 0 0 0 0 0 0 0
Totale 39.807